Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Thursday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

Mannatech stock opened at $8.42 on Thursday. Mannatech has a 52-week low of $6.75 and a 52-week high of $16.49. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The stock has a fifty day moving average price of $10.92 and a two-hundred day moving average price of $10.10. The firm has a market capitalization of $15.87 million, a P/E ratio of -10.39 and a beta of 1.06.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Wednesday, March 26th. The company reported $1.20 earnings per share (EPS) for the quarter. The firm had revenue of $29.01 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.